Literature DB >> 22580396

Significant peri-operative reduction in plasma osteopontin levels after coronary artery by-pass grafting.

Eftihia Sbarouni1, Panagiota Georgiadou, Constantinos Mihas, Antigoni Chaidaroglou, Demitris Degiannis, Vassilis Voudris.   

Abstract

OBJECTIVES: Osteopontin (OPN) is a multifunctional protein associated with vascular injury and has been linked to atherosclerosis and inflammation. We sought to investigate whether OPN changes in relation to coronary artery by-pass grafting (CABG) surgery. DESIGN AND METHODS: We studied 50 consecutive patients (63 ± 10 years old, 6 women and 44 men) undergoing elective CABG. Plasma OPN levels were determined by an enzyme-linked immunosorbent assay at baseline and in 24 and 72 h, post-operatively. Cardiac enzymes - creatine kinase, the MB isoenzyme of creatine kinase, troponin-I- and C-reactive protein (CRP) were also determined at all three time points.
RESULTS: OPN levels 72 h post-op decreased significantly compared to pre-op and 24h post-op levels (p<0.001) whereas there was no difference between the pre-op and first post-op values (p=0.57). The relative change in OPN levels between pre-op and 72 h post-op correlated negatively with absolute troponin-I levels at 72 h post-op (-0.51, p=0.005). OPN levels 72 h post-op correlated significantly with CRP at baseline (r=0.73, p=0.002).
CONCLUSIONS: OPN plasma concentrations decreased after CABG surgery in the early post-operative period. The significance of this observation needs further investigation.
Copyright © 2012 The Canadian Society of Clinical Chemists. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22580396     DOI: 10.1016/j.clinbiochem.2012.04.019

Source DB:  PubMed          Journal:  Clin Biochem        ISSN: 0009-9120            Impact factor:   3.281


  3 in total

1.  Osteopontin in Vascular Disease.

Authors:  Zoe Shin Yee Lok; Alicia N Lyle
Journal:  Arterioscler Thromb Vasc Biol       Date:  2019-04       Impact factor: 8.311

Review 2.  Clinical and Molecular Implications of Osteopontin in Heart Failure.

Authors:  Argen Mamazhakypov; Meerim Sartmyrzaeva; Akpay Sh Sarybaev; Ralph Schermuly; Akylbek Sydykov
Journal:  Curr Issues Mol Biol       Date:  2022-08-11       Impact factor: 2.976

3.  Osteopontin and Osteoprotegerin as Potential Biomarkers in Abdominal Aortic Aneurysm before and after Treatment.

Authors:  Konstantinos Filis; Vasilios Martinakis; George Galyfos; Fragiska Sigala; Dimitris Theodorou; Ioanna Andreadou; Georgios Zografos
Journal:  Int Sch Res Notices       Date:  2014-07-09
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.